All Articles

A top industry award reveals it's not just Laserfiche's new agentic AI that drives a 99% renewal rate, but a deep-seated culture of customer partnership.

As farmers face a historic squeeze, Leaf Agriculture's new funding aims to build the data plumbing for an AI revolution, turning data chaos into profit.

Beyond mere screens, a new wave of 'invisible' tech is turning walls into worlds, driving business and reshaping how we connect. Here's what it means.

As investors seek shelter from market swings without sacrificing growth, RILAs are booming. Pacific Life's latest enhancements signal a broader industry shift.

Bitget CFD's zero-fee launch and $10B daily volume signal a major push to merge crypto and TradFi. But what are the hidden costs of this convergence?

Emerging from stealth with $5.5M, Lium's 'agentic harness' aims to let AI understand seismic, satellite, and scientific data, unlocking new discoveries.

A landmark agreement gives Premier's 4,350-hospital network streamlined access to Bluesight’s AI-powered suite for drug diversion and supply chain management.

A groundbreaking study ranks NFL owners by their AI-rendered reputations, showing single scandals can erase decades of success, signaling a new era for PR.

Daniel Wolfe's appointment as Editor-in-Chief signals a major pivot for Digital Insurance, doubling down on AI as a definitive growth signal for the industry.

Millions suffer from chronic sciatica with few good options. A small biotech is betting on a novel, non-opioid drug to fix the problem, not just mask it.

A major financial outlook warns that geopolitical fragmentation, stubborn inflation, and a new AI arms race are creating a new reality for investors.

A seismic shift is underway in the beauty industry. The era of sprawling global supply chains is giving way to a new, agile model of local-first production.

Crum & Forster's recent marketing awards are more than trophies. They are a blueprint for how legacy firms can master innovation, from AI adoption to CEO-led narrative.

Beacon Biosignals is merging AI-driven brain monitoring with home sleep testing, creating a powerful new platform that could redefine neurological diagnostics.

Polish biotech firm Urteste S.A. enrolls its first patient in a pivotal trial for a non-invasive pancreatic cancer test, a milestone in the global race for early diagnosis.

Futuri launches TopLine Enterprise, promising massive ROI by automating sales admin. We analyze if its data-centric approach can cut through a crowded AI market.

MAIA Biotechnology isn't just opening a new trial site; it's accelerating its assault on a $70B market with a drug showing remarkable early results.

SEALSQ's CEO leads a crucial quantum semiconductor talk in Munich, highlighting the race to scale quantum tech and the urgent need for post-quantum security.

A new partnership brings enterprise-grade governance to AI-generated code, aiming to solve the growing security blind spot in automated software development.

Swedish freight-tech leader Einride's explosive Nasdaq debut validates a ten-year mission to build the resilient, autonomous future of supply chains.